Use of tissue type plasminogen activator in neonates: Case reports and review of the literature

American Journal of Perinatology

Volumn 13, Issue 4, 1996, Pages 216-222

  Smets, Koenraad ^a   Vanhaesebrouck, Piet ^b   Voet, Dirk ^b   Schelstraete, Petra ^b   Govaert, Paul ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Collateral circulation; Thrombus; Tissue type plasminogen activator

Indexed keywords

ALTEPLASE;

ARTERY THROMBOSIS; ARTICLE; BLEEDING; CASE REPORT; COLLATERAL CIRCULATION; DRUG USE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; VEIN THROMBOSIS;

HEMORRHAGE; HUMANS; INFANT; LIVER; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; VENA CAVA, INFERIOR;

EID: 0029875954     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994367     Document Type: Review

References (21)

1. Wigger HJ, Bransilver BR, Blanc WA. Thromboses due to catheterization in infants and children. J Pediatr 1970;76: 1-11
2. Van Overmeire B, Van Reempts PJ, Van Acker KJ. Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator. Arch Dis Child 1992;67:443-5
3. Kennedy LA, Drummond WH, Knight ME, et al. Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator.J Pediatr 1990;116:798-801
4. Guerin V, Boisseau MR, Fayon M. Efficiency of alteplase in the treatment of venous and arterial thrombosis in neonates. Am J Hematol 1993;42:236-7
5. Deeg KH, Wolfel D, Rupprecht T. Diagnosis of neonatal aortic thrombosis by colour Doppler sonography. Pediatr Radiol 1992;22:62-3
6. Anderson BJ, Keeley SR, Johnson ND. Caval thrombolysis in neonates using low doses of recombinant human tissuetype plasminogen activator, Anaesth Intens Care 1991; 19:22-7
7. Dillon PW, Fox PS, Berg CJ, et al. Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolvtic therapy J Pediatr Surg 1993;28:1264-9
8. Nowak-Gottl U, Schwabe D, Schneider W, et al. Thrombolysis with recombinat tissue-type plasminogen activator in renal venous thrombosis in infancy. Lancet 1992;340:1105
9. Rennie JM, Gibson T, Cooke RWI. Micromethod for bleeding time in the newborn. Arch Dis Child 1985;60:51-3
10. Levy M, Benson LN, Burrows PE, et al. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991;118:467-72
11. Bounameaux H, StassenJM, Seghers C, et al. Influence of fibrin and liver blood flow on the turnover and the systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator in rabbits. Blood 1986;67: 1493-7
12. Pyles LA, Picrpont MEM, Steiner ME, et al. Fibrinolysis by tissue plasminogen activator in a child with pulmonarv embolism. J Pediatr 1990;116:801-4
13. Asante-Korang A, Sreeram N, McKay R, et al Thrombolysis with tissue-type plasminogen activator following cardiac surgery in children. Int J Cardiol 1992;35:317-22
14. Martin U, Sponer G, Strein K. Influence of hepatic and renal failure on pharmacokinetic properties of the novel recombinant plasminogen activator BM 06.022 in rats. Drug Metab Dispos 1993;21:236-41
15. Tran Thang C, Fasel FelleyJ, Pralong G, et al. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Thromb Haemost 1989;62:651-3
16. Leiper K, Croll A, Booth NA, et al. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease. J Clin Pathol 1994;47:214-7
17. Nowak-Gottl U, Kreuz WD, Schwabe D, et al. Thromboryse mit rt-PA bei Kindern mit arteriellen und venösen Thrombosen - ein neuer Therapieansatz. Klin Pädiatr 1991;203:359-62
18. Marder VJ, Sherry S. Thrombolytic therapy: current status (second of two parts). N Engl J Med 1988;318:1585-95
19. Holden RW. Plasminogen activators: pharmacology and therapy. Radiology 1990;174:993-1001
20. Collen D, Scassen JM, Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. J Clin Invest 1983;71:368-76
21. Koppensteiner R, Minor E, Ahmadi R, et al. Low doses of recombinant human tissue-type plasminogen activator for local thrombolysis in peripheral arteries. Radiology 1988;168:877-8